Dr. Taber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
164 Summit Ave
Providence, RI 02906Phone+1 401-793-2920Fax+1 401-793-2859
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009- Brown UniversityResidency, Internal Medicine, 2003 - 2006
University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
RI State Medical License 2005 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cabazitaxel and Radiation For Patients With Prostate Cancer Start of enrollment: 2013 Jan 01
- Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 1 citationsTKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations.Madhu M. Ouseph, Angela Marie Taber, Humera Khurshid, Russell Madison, Bassam I. Aswad
Lung Cancer. 2019-08-15 - 56 citationsBrigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLCJessica J. Lin, Viola W. Zhu, Adam J. Schoenfeld, Beow Y. Yeap, Ashish Saxena
Journal of Thoracic Oncology. 2018-10-01 - Time to Take a Step Beyond the “High Risk Features”Thomas Ng, Angela Marie Taber
The Journal of Thoracic and Cardiovascular Surgery. 2018-04-17
Press Mentions
June Is Cancer Survivor Month: Screenings Save LivesJune 24th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
